You should contact your doctor immediately if you experience any of the following side effects while using retatrutide or similar medications: Severe and persistent abdominal pain that radiates to the back and is associated with nausea and fever, as these symptoms may indicate inflammation of the gallbladder or pancreas
Key Takeaways Retatrutide targets three hormones (GLP-1, GIP, glucagon), tirzepatide targets two (GLP-1, GIP), and semaglutide targets one (GLP-1) At 68 weeks, retatrutide achieved 28.7% average weight loss, tirzepatide approximately 22%, and semaglutide around 17% on the highest doses Side effects are similar across all three medications, mainly digestive issues like nausea and diarrhoea Retatrutide is not yet approved and won't be available until mid-2026 at the earliest Retatrutide is not yet approved and is not currently available in the UK Tirzepatide (Mounjaro) and semaglutide (Wegovy) are both available now in the UK through NHS or private providers By entering I agree to the Terms and Conditions
(You can check the FDA website to see if a company is registered.) The FDA has made an effort to crack down on unregistered 503B outsourcing facilities and has issued warnings to consumers that compounded medications might be ineffective or harmful to your health
Additionally, addressing emotional eating and building a supportive network are essential steps in your journey
Hims does offer anti-nausea meds to eligible patients, so either he did not get them or they did not do the job
What if my product arrives damaged or the seal is broken
